Skip to main content

IUSTI 2019

Tine Provinciael, our Quality Specialist and Nette Meers, our Biomedical Engineer are excited to join the latest scientific discussions on STI detection methods and how urine offers a unique solution in this field. They will also participate in the STI course organized as part of the conference to learn more about the latest recommendations for treatment and prevention of various STIs.

See you there!

Tallinn, Estonia

Disclaimer

Novosanis is a wholly owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology. The Colli-Pee® family, the heart of the company, allows volumetric and standardized collection of first-void urine. The platform consists of variants capturing a range of urine volumes for different application purposes. Urine collection through the Colli-Pee® device is easy, comfortable, and more accurate than a regular urine cup. First-void urine has shown to improve detection of infectious diseases, including sexually transmitted infections as well as for some cancers applications. The Colli-Pee® device enables immediate mixing of the first-void urine sample with a preservative, improving stability of the urine specimen. Novosanis markets its products worldwide and has a global customer base.